VEGFA and cancer: The use of these inhibitors is associated with relapse partly due to the activation of alternative pathways involving other VEGF family ligands and receptors, and thus, an understanding of the molecular biology of VEGFRs, as well as their pathophysiological roles, is important to improve cancer therapy.